Literature DB >> 21898226

The role of p23, Hop, immunophilins, and other co-chaperones in regulating Hsp90 function.

Marc B Cox1, Jill L Johnson.   

Abstract

Molecular chaperones are a diverse group of highly conserved proteins that transiently interact with partially folded polypeptide chains during normal cellular processes, such as protein translation, translocation, and disassembly of protein complexes (1). Prior to folding or after denaturation, hydrophobic residues that are normally sequestered within a folded protein are exposed to the aqueous environment and are prone to aggregation or misfolding. Multiple classes of molecular chaperones, such as Hsp70s and Hsp40s, recognize and transiently bind polypeptides with exposed hydrophobic stretches in order to prevent misfolding. Other types of chaperones, such as Hsp90, have more specialized functions in that they appear to interact with only a subset of cellular proteins. This chapter focuses on the role of Hsp90 and partner co-chaperones in promoting the folding and activation of a diverse group of proteins with critical roles in cellular signaling and function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898226     DOI: 10.1007/978-1-61779-295-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression.

Authors:  Sachiyo Okayama; Levy Kopelovich; Gabriel Balmus; Robert S Weiss; Brittney-Shea Herbert; Andrew J Dannenberg; Kotha Subbaramaiah
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

Review 2.  Mechanistic Asymmetry in Hsp90 Dimers.

Authors:  Julia M Flynn; Parul Mishra; Daniel N A Bolon
Journal:  J Mol Biol       Date:  2015-04-03       Impact factor: 5.469

3.  Novobiocin analogues with second-generation noviose surrogates.

Authors:  Huiping Zhao; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2012-11-22       Impact factor: 2.823

4.  Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy.

Authors:  Stuart K Calderwood
Journal:  Discov Med       Date:  2013-03       Impact factor: 2.970

Review 5.  Cdc37 as a co-chaperone to Hsp90.

Authors:  Stuart K Calderwood
Journal:  Subcell Biochem       Date:  2015

6.  Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.

Authors:  Mehdi Mollapour; Dimitra Bourboulia; Kristin Beebe; Mark R Woodford; Sigrun Polier; Anthony Hoang; Raju Chelluri; Yu Li; Ailan Guo; Min-Jung Lee; Elham Fotooh-Abadi; Sahar Khan; Thomas Prince; Naoto Miyajima; Soichiro Yoshida; Shinji Tsutsumi; Wanping Xu; Barry Panaretou; William G Stetler-Stevenson; Gennady Bratslavsky; Jane B Trepel; Chrisostomos Prodromou; Len Neckers
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

7.  The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding.

Authors:  Mark R Woodford; Diana M Dunn; Adam R Blanden; Dante Capriotti; David Loiselle; Chrisostomos Prodromou; Barry Panaretou; Philip F Hughes; Aaron Smith; Wendi Ackerman; Timothy A Haystead; Stewart N Loh; Dimitra Bourboulia; Laura S Schmidt; W Marston Linehan; Gennady Bratslavsky; Mehdi Mollapour
Journal:  Nat Commun       Date:  2016-06-29       Impact factor: 14.919

Review 8.  Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.

Authors:  Lindsey B Shelton; John Koren; Laura J Blair
Journal:  Front Neurosci       Date:  2017-12-22       Impact factor: 4.677

Review 9.  Molecular cochaperones: tumor growth and cancer treatment.

Authors:  Stuart K Calderwood
Journal:  Scientifica (Cairo)       Date:  2013-04-17

10.  c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells.

Authors:  Diana M Dunn; Mark R Woodford; Andrew W Truman; Sandra M Jensen; Jacqualyn Schulman; Tiffany Caza; Taylor C Remillard; David Loiselle; Donald Wolfgeher; Brian S J Blagg; Lucas Franco; Timothy A Haystead; Soumya Daturpalli; Matthias P Mayer; Jane B Trepel; Rhodri M L Morgan; Chrisostomos Prodromou; Stephen J Kron; Barry Panaretou; William G Stetler-Stevenson; Steve K Landas; Len Neckers; Gennady Bratslavsky; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Cell Rep       Date:  2015-07-30       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.